INTRODUCTION
antimalarial resistance, which was the single most important factor in its recent worldwide resurgence. 23, 41 Of these, the most important is resistance to chloroquine (CQ) in Plasmodium falciparum, because P. falciparum is responsible for most morbidity and mortality, especially the deaths of children under 5 years of age in sub-Saharan Africa. 3 For these reasons and because resistance is now emerging to the artemisinins and the atovaquone + proguanil (Malarone) combination, 14,20,34 the development of antimalarials effective against drug-resistant parasitesthat are affordable by the people in greatest need -is an urgent global health priority.
The established safety record of CQ, its ease of synthesis and low cost led us to examine the structure-activity relationships (SARs) responsible for the anti-parasite activity of the 4-aminoquinolines (4-AQs) [10] [11] 27 with the goal of identifying the factors responsible for their activity against CQ-resistant parasites. AQ analogue design and synthesis during the past 5-10 years in combination with biologic testing against CQ-susceptible and -resistant P. falciparum has also yielded molecular insights into the mechanisms of AQ action and resistance. [28] [29] [30] [31] In this report, we present structure-activity analyses for 108 AQ analogues -including 68 newly synthesized compounds -to clarify the relationship between the chemical structures of the AQs and their anti-parasite activity.
A main purpose of quantitative structure-activity relationship (QSAR) analyses is to make activity predictions for unknown compounds in order to guide the structure-based design of new analogues. Because we plan to extend the search for more potent AQ analogues using an iterative molecular design approach, useful quantitative models must have the ability to be readily extended to incorporate additional compounds. Therefore, we used computer-generated 3-D structures and chemical descriptors. This manuscript examines 108 AQs using comparative molecular field (CoMFA) 8 and similarity indices analyses (CoMSIA), 26 the 2-D hologram QSAR (HQSAR) 33, 37 and UNITY molecular fingerprint 6 paradigms. To eliminate bias from the selection of a single test set to examine the predictive ability of QSAR models, we randomly assigned 20 molecules to 20 different test sets, and used the excluded 88 compounds as the associated training set in each case.
Partial least squares (PLS) analysis reduces the complexity of a QSAR model by sorting the large number of descriptors into a small number of orthogonal principal components to facilitate least-squares fitting. However, these components still contain large numbers of descriptors.
Inevitably, many of these descriptors are affected by the inherent noise of the method and the uncertainty of the biological data. Several methods have been described to eliminate these uninformative descriptors. 43 These methods include the stability (mean/SD) of PLS weights 2 or PLS coefficients 5 and retain only the most stable descriptors in the final QSAR models. In this study descriptor normalization was used to prevent descriptors with large magnitudes or variances from swamping other descriptors. Ranking the PLS contributions for each of the normalized descriptors identified those that best predicted the antiparasite activities (IC 50 s) of the unknown test AQs. In this way, the model was chosen by its ability to predict, rather than to fit the data.
MATERIALS AND METHODS
Synthesis of AQ Analogues. AQ analogues were synthesized as described previously.
Briefly, as an example, 7-chloro-AQs were synthesized by the condensation of m-chloroaniline Table 1 and shown in detail in Table 2 for the AQ analogues which have not been reported previously. Data for the 40 4-AQ analogues which have been reported previously are available in those manuscripts. [10] [11] 32 Synthetic and analytical data for the remaining compounds will be published elsewhere (manuscript in preparation).
QSAR Data Set. These computational studies examined 108 4-AQ analogues based on CQ.
These AQs consisted of 72 7-Cl, 6 7-F, 7 7-Br, 6 7-I, 7 7-CF 3 , 6 7-OMe, 1 6-Cl, 1 Table 3 .
RESULTS AND DISCUSSION
At a time when there is an unprecedented global effort to control and potentially eliminate malaria, 22 antimalarial resistance remains the single most important obstacle to success. This is As a result, increasing the number of AQs active against CQ-resistant P. falciparum, and thus expanding the depleted upstream pipeline for antimalarial development is an overwhelmingly important step in the path to the control and elimination of malaria. This strategic argument has recently been strengthened by our Phase 1 (safety and pharmacokinetic) studies of the lead compound (AQ-13) in human subjects. Those studies have shown that AQ-13 is economical (cost of goods $0.03 per dose), as safe as CQ in human subjects (one of the safest drugs known), produces blood levels and bioavailability similar to those of CQ, and has no identifiable cardiac, neurologic or other toxicities at oral doses equivalent to 600, 1200, 1500 or 1800 mg CQ base.
32
SARs against P. falciparum. Based on the data reported here (Table 2 ) and in our previous studies, 10-11,32 common features of AQs active against both CQ-susceptible and -resistant P. Optimization of the descriptors had a profound effect (2-to 3-fold) on the q 2 values for the CQ-susceptible parasites, and a much smaller effect with the CQ-resistant parasites ( Figure 1) .
Of all the AQs tested, only compound 18 was profoundly inactive against the CQ-susceptible parasites giving a narrower range of data for this outlier as compared with the CQ-resistant parasite IC 50 data ( Table 2 ). For both data sets, the 2-D fingerprint and 3-D descriptors yielded similar predictive q 2 values and standard errors of prediction (Figures 1-3) . However, applying the same optimizations to the default descriptors without normalization produced little improvement in the QSAR statistics (data not shown). A potential antimalarial drug must diffuse to, and accumulate in the acidic food vacuole of P. falciparum to be active -crossing several cell membrane/aqueous interfaces. Accumulation in the acidic vacuole is driven by a gradient of ≈2 pH units. Once inside the parasite food vacuole, protonation prevents the putative drug from diffusing out thus allowing pharmacologically active concentrations of drug to accumulate. Since this transport requires both aqueous and lipid solubility, migration and protonation, we augmented the QSAR descriptors with calculated pK a , log P and log D values. However, the addition of these descriptors did not enhance the predictive ability of these models.
Final QSAR Model. The HQSAR, UFP, CoMFA and CoMSIA and descriptors each produced QSAR models with useful predictabilities (Figures 1-3) . Inspection of the contributions to the final QSAR models showed that descriptor refinement by iterative optimization increased the importance of QSAR contributions from the minor descriptors in the SYBYL default PLS analyses ( Figure 4 ) whilst simultaneously increasing the predictability of the models (Figure 3 ). Figure 5B ). These results suggest that hydrophilicity with short side chains should produce greater activity against CQ-resistant parasites and thus that future syntheses of aminoquinolines should explore the inclusion of hydrophilic moieties in this region.
CONCLUSIONS
The results reported here demonstrate that it is possible to develop substantial numbers of AQs active against both CQ-susceptible and -resistant P. falciparum (59 of 108 AQs=55%). 
